Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 16, 2024 08:00 ET | Fortress Biotech, Inc.
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
journeylogo (1).jpg
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15, 2024 16:01 ET | Journey Medical Corporation
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
GRI Bio Announces Pricing of $5.5 Million Public Offering
February 02, 2024 08:00 ET | GRI Bio, Inc.
LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell...
buja logo-01.png
Bukit Jalil Global Acquisition 1 Ltd. Announces the Separate Trading of its Ordinary Shares, Warrants, and Rights, Commencing on August 21, 2023
August 17, 2023 08:00 ET | Bukit Jalil Global Acquisition 1 Ltd.
New York, NY, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Bukit Jalil Global Acquisition 1 Ltd. (the “Company”) (Nasdaq: BUJA), a blank check company, today announced that, commencing on August 21, 2023,...
April 06, 2022 08:30 ET | Celsion Corporation
LAWRENCEVILLE, NJ, April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...
Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock
January 10, 2022 20:45 ET | Celsion CORP
LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today...
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
December 01, 2021 15:25 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with certain...
KT graphic BLUE.png
MICHAEL SHILLIN INVESTOR ALERT: National Investor Fraud Law Firm KlaymanToskes Commences Investigation of Financial Advisor Michael Shillin in Light of SEC lawsuit and FINRA bar
October 28, 2021 16:53 ET | Klayman & Toskes P.A.
WISCONSIN, Oct. 28, 2021 (GLOBE NEWSWIRE) -- National investor fraud law firm, KlaymanToskes (“KT”), has commenced an investigation of potential FINRA arbitration claims of financial advisor Michael...
COGI logo 2019.jpg
Coda Octopus Group to Present Fireside Chat with Alliance Global Partners
September 20, 2021 06:00 ET | Coda Octopus Group, Inc.
ORLANDO, FL, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (CODA) (Nasdaq: CODA) a global leader in real time 3D/4D/5D and 6D underwater imaging technologies, announced today that its...
Muscle Maker, Inc. Announces $10 Million Private Placement Priced At-The-Market
April 07, 2021 08:30 ET | Muscle Maker, Inc.
League City, Texas, April 07, 2021 (GLOBE NEWSWIRE) -- Muscle Maker, Inc. (Nasdaq: GRIL) (“Muscle Maker” or the “Company”) today announced it has entered into a definitive agreement for a private...